Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours
- 2 December 2014
- journal article
- Published by Springer Nature in European Radiology
- Vol. 25 (3) , 751-759
Abstract
Preoperative suspicion of malignancy in pancreatic neuroendocrine tumours (pNETs) is mostly based on tumour size. We retrospectively reviewed the contrast enhancement pattern (CEP) of a series of pNETs on multiphasic multidetector computed tomography (MDCT), to identify further imaging features predictive of lesion aggressiveness. Sixty pNETs, diagnosed in 52 patients, were classified based on CEP as: type A showing early contrast enhancement and rapid wash-out; type B presenting even (B1) or only (B2) late enhancement. All tumours were resected allowing pathologic correlations. Nineteen pNETs showed type A CEP (5–20 mm), 29 type B1 CEP (5–80 mm) and 12 type B2 (15–100 mm). All tumours were classified as well differentiated tumours, 19 were benign (WDt-b), 15 with uncertain behaviour (WDt-u) and 26 carcinomas (WDC). None of A lesions were malignant (12 WDt-b; 7 WDt-u), all B2 lesions were WDC, 7 B1 lesions were WDt-b, 8 WDt-u and 14 WDC; 4/34 (12 %) lesions ≤2cm were WDC. CEP showed correlation with all histological prognostic indicators. Correlating with the lesion grading and other histological prognostic predictors, CEP may preoperatively suggest the behaviour of pNETs, assisting decisions about treatment. Moreover CEP allows recognition of malignant small tumours, incorrectly classified on the basis of their dimension. • Neuroendocrine pancreatic tumours (pNETs) show different post-contrast behaviour on CT. • P NETs can be classified on the basis of contrast enhancement into three categories. • CT classification of pNETs shows strong correlation with histological prognostic factors. • CT pattern may suggest the optimal management of pNETs.Keywords
This publication has 32 references indexed in Scilit:
- Neuroendocrine Neoplasms of the Gastroenteropancreatic System: Pathology and ClassificationHormone and Metabolic Research, 2011
- Pancreatic endocrine tumorsLaboratory Investigation, 2011
- NANETS Treatment GuidelinesPancreas, 2010
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patientsLaboratory Investigation, 2010
- The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statementVirchows Archiv, 2010
- Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreasBritish Journal of Surgery, 2008
- Pancreatic Endocrine TumorsGastroenterology Clinics of North America, 2007
- Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine TumorsClinical Cancer Research, 2007
- Endocrine tumours of the pancreasBest Practice & Research Clinical Gastroenterology, 2005
- Tumorigenesis and the angiogenic switchNature Reviews Cancer, 2003